Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and Metabolite Profiling of Pitolisant in Healthy Men
NCT02929342Phase 1Completed
- Sponsor
- Bioprojet
- Start
- Jul 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of pitolisant in narcolepsy, sponsored by Bioprojet. Primary endpoints: Mass balance recovery of total radioactivity (Ae) in urine, faeces and expired air, Peak Plasma Concentration and 6 more. Started Jul 2016; status: completed.
02
Drugs
pitolisant
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT02929342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02929342.